Student Research Committee, Nutrition Research Center, School of Public Health & Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Breastfeed Med. 2013 Apr;8:217-22. doi: 10.1089/bfm.2012.0078. Epub 2013 Feb 11.
The aims of this study were to determine the effects of synbiotic (probiotic plus prebiotic) supplementation on total antioxidant capacity (TAC) and malondialdehyde (MDA) levels of human breastmilk.
In this randomized, double-blind, placebo-controlled trial, 80 lactating mothers were randomly divided into two groups to receive a daily supplement of synbiotic (n=40) or a placebo (n=40) for 30 days. Information on dietary intake was collected from lactating women using the 24-hour recall method for 3 days before and after supplementation. The TAC was measured by using a Randox (Crumlin, County Antrim, United Kingdom) assay, and the MDA level of breastmilk as thiobarbitaric acid complexes was measured by the fluorometry method. Data analysis was carried out using Nutritionist IV (Axxya Systems, Stafford, TX) and SPSS (SPSS, Inc., Chicago, IL).
The TAC of breastmilk increased significantly from 0.312±0.16 to 0.481±0.2 mmol/L in the supplemented group (p<0.039), whereas it decreased from 0.317±0.18 to 0.255±0.13 mmol/L in the placebo group (p>0.13). Although the MDA level decreased slightly from 1.62±0.69 to 1.6±0.95 μmol/L in the supplemented group, it increased significantly in the placebo group from 1.71±0.86 to 2.16±0.277 μmol/L after the experimental period (p<0.001). Also, maternal vitamin A, E, and C, zinc, and selenium intake did not change significantly in both groups during the study period. Moreover, no significant correlation was found between weight for age Z-score of infants and TAC and MDA levels in breastmilk.
Based on these results, synbiotic supplementation may have positive effects on the TAC and MDA levels in breastmilk; however, these findings require confirmation from future trials.
本研究旨在探讨合生元(益生菌加益生元)补充剂对人乳总抗氧化能力(TAC)和丙二醛(MDA)水平的影响。
在这项随机、双盲、安慰剂对照试验中,将 80 名哺乳期母亲随机分为两组,分别接受每日补充合生元(n=40)或安慰剂(n=40),为期 30 天。在补充前后的 3 天内,采用 24 小时回顾法收集哺乳期妇女的饮食摄入信息。采用 Randox(Crumlin,County Antrim,英国)测定法测定 TAC,采用荧光法测定乳中 MDA 水平作为硫代巴比妥酸复合物。数据分析采用 Nutritionist IV(Axxya Systems,Stafford,TX)和 SPSS(SPSS,Inc.,Chicago,IL)进行。
补充组的乳 TAC 从 0.312±0.16 显著增加到 0.481±0.2 mmol/L(p<0.039),而安慰剂组则从 0.317±0.18 下降到 0.255±0.13 mmol/L(p>0.13)。虽然补充组的 MDA 水平从 1.62±0.69 略微下降到 1.6±0.95 μmol/L,但在安慰剂组中,在实验期间,MDA 水平从 1.71±0.86 显著增加到 2.16±0.277 μmol/L(p<0.001)。此外,在研究期间,两组的母体维生素 A、E、C、锌和硒的摄入量均无明显变化。而且,婴儿的年龄体重 Z 评分与乳中 TAC 和 MDA 水平之间没有发现显著相关性。
基于这些结果,合生元补充剂可能对乳中 TAC 和 MDA 水平有积极影响,但这些发现需要进一步的临床试验来证实。